Literature DB >> 18523064

Causes and consequences of increased glucose metabolism of cancers.

Robert J Gillies1, Ian Robey, Robert A Gatenby.   

Abstract

In this review we examine the mechanisms (causes) underlying the increased glucose consumption observed in tumors within a teleological context (consequences). In other words, we will ask not only "How do cancers have high glycolysis?" but also, "Why?" We believe that the insights gained from answering the latter question support the conclusion that elevated glucose consumption is a necessary component of carcinogenesis. Specifically we propose that glycolysis is elevated because it produces acid, which provides an evolutionary advantage to cancer cells vis-à-vis normal parenchyma into which they invade.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18523064     DOI: 10.2967/jnumed.107.047258

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  244 in total

1.  Unraveling the complex regulatory relationships between metabolism and signal transduction in cancer.

Authors:  Michelle L Wynn; Sofia D Merajver; Santiago Schnell
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

2.  Prognostic significance of glucose transporter-1 (GLUT1) gene expression in rectal cancer after preoperative chemoradiotherapy.

Authors:  Susumu Saigusa; Yuji Toiyama; Koji Tanaka; Yoshinaga Okugawa; Hiroyuki Fujikawa; Kohei Matsushita; Keiichi Uchida; Yasuhiro Inoue; Masato Kusunoki
Journal:  Surg Today       Date:  2011-11-11       Impact factor: 2.549

Review 3.  Tumor cell metabolism: an integral view.

Authors:  Susana Romero-Garcia; Jose Sullivan Lopez-Gonzalez; José Luis Báez-Viveros; Dolores Aguilar-Cazares; Heriberto Prado-Garcia
Journal:  Cancer Biol Ther       Date:  2011-12-01       Impact factor: 4.742

Review 4.  Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy.

Authors:  Anwar R Padhani; Aftab Alam Khan
Journal:  Target Oncol       Date:  2010-04-11       Impact factor: 4.493

5.  FDG PET in Prostate Cancer.

Authors:  Hossein Jadvar
Journal:  PET Clin       Date:  2009-04-01

6.  Changing the energy of an immune response.

Authors:  Meghan M Delmastro-Greenwood; Jon D Piganelli
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

7.  Prognostic value of FDG uptake in primary inoperable non-small cell lung cancer.

Authors:  An-Na Tong; Shao-Rong Han; Peng Yan; Hai Gong; Hui Zhao; Hui Yao; Yan-Ming Wang
Journal:  Med Oncol       Date:  2013-12-11       Impact factor: 3.064

8.  Src Inhibition Blocks c-Myc Translation and Glucose Metabolism to Prevent the Development of Breast Cancer.

Authors:  Shalini Jain; Xiao Wang; Chia-Chi Chang; Catherine Ibarra-Drendall; Hai Wang; Qingling Zhang; Samuel W Brady; Ping Li; Hong Zhao; Jessica Dobbs; Matt Kyrish; Tomasz S Tkaczyk; Adrian Ambrose; Christopher Sistrunk; Banu K Arun; Rebecca Richards-Kortum; Wei Jia; Victoria L Seewaldt; Dihua Yu
Journal:  Cancer Res       Date:  2015-09-17       Impact factor: 12.701

9.  Is higher lactate an indicator of tumor metastatic risk? A pilot MRS study using hyperpolarized (13)C-pyruvate.

Authors:  He N Xu; Stephen Kadlececk; Harrilla Profka; Jerry D Glickson; Rahim Rizi; Lin Z Li
Journal:  Acad Radiol       Date:  2014-02       Impact factor: 3.173

Review 10.  The Role of Autophagy in the Maintenance of Stemness and Differentiation of Mesenchymal Stem Cells.

Authors:  Francesca Vittoria Sbrana; Margherita Cortini; Sofia Avnet; Francesca Perut; Marta Columbaro; Angelo De Milito; Nicola Baldini
Journal:  Stem Cell Rev Rep       Date:  2016-12       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.